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Abstract 
Background: Neisseria gonorrhoeae is a Gram‑negative bacterium which affects the urethra, throat, rectum and cer‑
vix of patients and often associated with sexually transmitted infections. The global epidemiology of the disease is not 
well characterised especially in resource constraint countries due to poor diagnostic capacity and inefficient reporting 
systems. Although important, little is known about the propensity of this bacterium to cause sepsis in immunocom‑
petent individuals.
Case presentation: A 32‑year‑old female presented with fever and generalised malaise to a rural hospital in Ghana. 
The patient had previously been diagnosed as having enteric fever from a neighbouring health facility. Blood and 
urine samples were collected from the patient and cultured using standard microbiological and molecular tech‑
niques. Neisseria gonorrhoeae was isolated from the blood which was resistant to penicillin, ciprofloxacin and cotri‑
moxazole. The patient recovered following ceftriaxone and azithromycin treatment.
Conclusion: This case highlights the importance of N. gonorrhoeae in causing sepsis and emphasises the need for 
blood culture investigation in diagnosis of patients presenting with fever.
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Background
Neisseria gonorrhoeae (N. gonorrhoeae) is a Gram-nega-
tive intracellular diplococcus bacterium associated with 
sexually transmitted infections (STIs). The organism 
causes gonorrhoeae; a disease which affects the urethra, 
throat, rectum and cervix of patients. The global epide-
miology of the disease is not well characterised due to 
poor diagnostic capacity and inefficient reporting sys-
tems. Globally, it is estimated that about 106 million of 
occur annually [1]. It is the second commonly reported 
STI and is most prevalent in the age group of 15–49 years 
[2] Although about 87% of N. gonorrhoeae infections 
occur in symptomatic individuals, few infections (about 
13%) progress asymptomatically [3]. The N. gonorrhoeae 
bacterium has become a major public health concern 
because of its increasing resistance to common antibiot-
ics including penicillin, tetracycline, sulphonamides and, 
more recently, quinolones [1, 2].
In rare circumstances, gonococcal infection may result 
in sepsis and septic shock [4]. Gonococcal sepsis is most 
common in young women, but may develop in sexually 
active persons of any age. Reports on the occurrence of 
gonococcal sepsis in developing countries, especially 
within Africa are limited. Here, we report a case of gono-
coccal sepsis in a 32-year old female from a rural com-
munity of Ghana.
Case presentation
A 32-year-old female trader presented to a hospital in 
the Ashanti region of Ghana, with 3-weeks history of 
generalised malaise and fever. Prior to her presenta-
tion, she was treated in a neighbouring hospital as a 
presumed case of enteric fever. On direct questioning, 
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the patient had no known history of chronic underlying 
medical condition.
On examination, she weighed 73.2  kg, was slightly 
pale and febrile with a temperature of 38.5  °C. Exami-
nation of her body systems including the cervix and 
vagina were all normal. Based on the clinical findings, a 
provisional diagnosis of enteric fever was made.
Preliminary laboratory test for HIV and malaria were 
all negative. Her full blood count showed a low haemo-
globin concentration of 8.7  g/dL and raised white cell 
count of 12.4 × 103 cells/µL.
Liver function test showed high aspartate transami-
nase (AST) of 151 U/L and alanine transaminase (ALT) 
of 74  U/L. Her CD4 count was 1899  cells/mm3 and 
CD4/CD3 ratio was 0.71. Pending results for micro-
biological investigations, the patient was empirically 
administered with 500  mg of ciprofloxacin 12 hourly 
daily.
Blood and urine were collected for microbiologi-
cal cultures. Blood sample was collected into Beckton 
Dickinson(BD) adult aerobic blood culture bottle (BD, 
Baltimore, US) and incubated in Bactec Machine at 
35 °C (9050, BD).
The blood culture yielded a fastidious bacterium with 
small sized and creamy non-haemolytic colonies. Gram 
stain of the colonies showed Gram negative diplococci. 
Oxidase and catalase tests proved positive. The identity 
of the bacteria was determined by first using Analytic 
Profile Index (API) specific for Neisseria spp. and Hae-
mophilus spp. (API NH, Biomerieux) and then confirm-
ing with 16S PCR method. The API kit showed a 100% 
consistency with N. gonorrhoeae.
For molecular identification, the 16S rRNA gene 
sequence of this bacterium was determined according 
to the procedure described previously [5]. Briefly DNA 
was extracted from the pure culture using Spherolyse 
extraction kit (Hain Lifesciense GmbH, Germany). 
The 16S rDNA was amplified using primer pair 8F and 
1492R and the resulting sequence was checked using 
DECIPHER (version 2.2.0).The final sequence generated 
was deposited in NCBI GenBank under the MF509590 
and exhibits 99% (1440/1442) sequence identity to N. 
gonorrhoeae strain NCTC 8375 (NR_026079.1).
Antimicrobial susceptibility testing was performed 
on the isolate using the Kirby Baur disc diffusion 
method and following the Clinical and Laboratory 
Standards Institute guideline [6] The isolate showed 
resistance to ciprofloxacin, cotrimoxazole and penicil-
lin but sensitivity to ceftriaxone, chloramphenicol and 
azithromycin. The patient’s prescription was amended 
to include ceftriaxone and azithromycin and her condi-
tion improved clinically.
Discussions and conclusions
Gonococcal bacteremia is a rare condition affecting less 
than 3% of patients with gonorrhoea [7]. Isolated cases 
reported in the Korean population identified viral hepa-
titis and liver cirrhosis as risk factors for gonococcal 
bacteremia [8]. Other risk factors identified include the 
pathogenicity of the infecting strain, pregnancy, acquired 
complement deficiencies, systemic lupus erythematosus, 
sickle cell disease and splenectomy [8–10].
This patient does not have any of the underlying host 
factors mentioned above. Her HIV test was negative and 
a further CD4 cell population was also adequate thus rul-
ing out any possibility of immunosuppression. We sur-
mise that our patient might have been infected based 
on the virulence of the pathogen. It is possible that pro-
longed asymptomatic carriage of specific bacterial strains 
increases the risk of invasive diseases leading to sepsis. In 
the early 1980s, O’Brien determined that specific strains 
of N. gonorrhoeae with outer membrane porin isoform 
(PorB1b) seem to have increased permissive host cell 
invasion compared to others without those factors [9]. 
More studies on the pathogenicity and the genetic diver-
sity of gonococcal strains would be helpful in under-
standing the mechanisms of gonococcal infections.
We also found the liver function markers (AST and 
ALT) of the patient as abnormal. Some authors have 
similarly reported abnormalities in liver enzymes of 
subjects [11, 12]. One common complication associated 
with gonococcal sepsis is perihepatitis [13]. Perihepati-
tis occurs by direct extension of the N. gonorrhoeae from 
the fallopian tubes to the liver capsule resulting in acute 
inflammation of the liver [13]. Other studies have simi-
larly identified gonococcal bacteraemia in patients pre-
senting with abnormal liver parameters, thus suggesting 
a possible association [11, 12].
Another important finding in this patient was the 
apparent lack of urogenital symptoms consistent with 
genital gonococcal infections. Thorough examination of 
the vagina and cervix did not show any signs of gono-
coccal infection. Other authors have similarly identified 
gonococcal infection in patients without history of uro-
genital symptoms [9]. About 50% of blood cultures were 
found to be positive in those cases although cultures 
from other body sites such as the synovial fluids and skin, 
were negative [14].
The isolated bacterium was also found to be resistant 
to common therapeutic agents including penicillin, cip-
rofloxacin and cotrimoxazole. This finding agrees with 
the recent report issued by the WHO on the growing 
gonococcal-associated antibiotic resistance and the need 
to strengthen antimicrobial surveillance of gonococcal 
infections [15].
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Our report brings to fore the importance of taking 
blood cultures and administering the right kind of anti-
biotics for all fever related conditions that present to the 
hospital. This particular infection could have been missed 
if a blood culture had not been performed on the patient.
Further surveillance and investigation into the mecha-
nisms of gonococcal invasion is therefore recommended 
infections.
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